Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)

Phase Distribution

Ph not_applicable
4
80%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

withdrawn120%
completed480%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
OTHER
Total Trials
5